# MAIA BIOTECHNOLOGY, INC.: Novel Telomere-Targeting Therapy for Advanced Non-Small Cell Lung Cancer

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | MAIA BIOTECHNOLOGY, INC. |
| Location | CHICAGO, IL |
| Project | Novel Telomere-Targeting Therapy for Advanced Non-Small Cell Lung Cancer |
| Project number | 5R44CA309843-02 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $770,168 |
| Awarded | 2026-09-17 |
| Project period | 2025-09-09 to 2028-08-31 |
| UEI | NPLUZJSWA853 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11411298). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.